Pier Capital, LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 185 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.

Quarter-by-quarter ownership
Pier Capital, LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$5,017,313
+29.0%
76,066
+1.1%
0.76%
+19.5%
Q4 2022$3,889,471
+2.8%
75,217
+35.8%
0.64%
-2.0%
Q3 2022$3,783,000
-35.8%
55,384
-57.5%
0.65%
-35.3%
Q2 2022$5,894,000
-10.9%
130,340
+0.1%
1.00%
+19.1%
Q1 2022$6,616,000
-36.9%
130,208
-41.3%
0.84%
-23.7%
Q4 2021$10,491,000
+104.0%
221,901
+42.2%
1.11%
+107.5%
Q3 2021$5,143,000156,0310.53%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders